Clinical Trial Update: Safety and Efficacy of Isomyosamine in Reducing Inflammation and Treating Muscle Loss in Older Adults After Hip or Thigh Bone Fractures [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Isomyosamine for safety and efficacy in reducing inflammation and treating muscle loss (sarcopenia) and frailty in older adult…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Frailty
• Sarcopenia

Drugs mentioned

• Isomyosamine (Isomyosamine)

Snippet

Sponsor: TNF Pharmaceuticals, Inc. | Conditions: Sarcopenia in Elderly, Frailty | Phase 2 | Status: NOT_YET_RECRUITING